ConductScience.org, home

Paper6287350

Orthostatic hypotension in familial amyloid polyneuropathy: treatment with DL-threo-3,4-dihydroxyphenylserine.

Suzuki T and 6 others. Neurology, 1981. Cited by 56 papers, by iCite.

Cite this record

ConductScience Library. Orthostatic hypotension in familial amyloid polyneuropathy: treatment with DL-threo-3,4-dihydroxyphenylserine. Papers, record 6287350. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6287350

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Orthostatic hypotension in familial amyloid polyneuropathy: treatment with DL-threo-3,4-dihydroxyphenylserine.
PubMed
Journal
Neurology
PubMed
Year
1981
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
56
iCite
Relative citation ratio, by iCite
2.52
iCite
Revised in PubMed
2019-05-14
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Suzuki TT
2Higa SS
3Sakoda SS
4Hayashi AA
5Yamamura YY
6Takaba YY
7Nakajima AA

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AmyloidosisMajor topic
DroxidopaMajor topic
Hypotension, OrthostaticMajor topic
Peripheral Nervous System DiseasesMajor topic
SerineMajor topic
Adult
Blood Pressure
Female
Humans
Male
Middle Aged
Norepinephrine
Tyrosine

Source PubMed

Download CSV of topics

Cited by17

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 56 citations.

PMIDTitleJournalYearIn PapersSource
34812056Effects of Manipulation of Noradrenergic Activities on the Expression of Dopaminergic Phenotypes in Aged Rat Brains.ASN Neuro2021https://conductscience.org/library/papers/34812056PubMed
31452021Orthostatic hypotension in hereditary transthyretin amyloidosis: epidemiology, diagnosis and management.Clin Auton Res2019https://conductscience.org/library/papers/31452021PubMed
29705971Roles of catechol neurochemistry in autonomic function testing.Clin Auton Res2018https://conductscience.org/library/papers/29705971PubMed
28623419Droxidopa for symptomatic neurogenic orthostatic hypotension: what can we learn?Clin Auton Res2017https://conductscience.org/library/papers/28623419PubMed
28124174The Clinical Autonomic Research journal 2017 and onward.Clin Auton Res2017https://conductscience.org/library/papers/28124174PubMed
26635194Freezing of Gait in Parkinsonism and its Potential Drug Treatment.Curr Neuropharmacol2016https://conductscience.org/library/papers/26635194PubMed
26255205Deficient vesicular storage: A common theme in catecholaminergic neurodegeneration.Parkinsonism Relat Disord2015https://conductscience.org/library/papers/26255205PubMed
26092297Droxidopa in neurogenic orthostatic hypotension.Expert Rev Cardiovasc Ther2015https://conductscience.org/library/papers/26092297PubMed
25973863Sudomotor innervation in transthyretin amyloid neuropathy: Pathology and functional correlates.Ann Neurol2015https://conductscience.org/library/papers/25973863PubMed
9182250Amine precursor amino acid therapy: from neurochemical basis to clinical aspects.Neurochem Res1996https://conductscience.org/library/papers/9182250PubMed
8676171Acute pandysautonomia: mass spectrometric and histopathological studies of the sympathetic nervous system during long term L-threo-3,4-dihydroxyphenylserine treatment.J Neurol Neurosurg Psychiatry1996https://conductscience.org/library/papers/8676171PubMed
6818040Pharmacokinetic studies of oral L-threo-3,4-dihydroxyphenylserine in normal subjects and patients with familial amyloid polyneuropathy.Eur J Clin Pharmacol1982https://conductscience.org/library/papers/6818040PubMed
3937060DL-threo-DOPS as a precursor of noradrenaline.Naunyn Schmiedebergs Arch Pharmacol1985https://conductscience.org/library/papers/3937060PubMed
3086752Reversal of the reserpine-induced ptosis by L-threo-3,4-dihydroxy-phenylserine (L-threo-DOPS), a (-)-norepinephrine precursor, and its potentiation by imipramine or nialamide.Naunyn Schmiedebergs Arch Pharmacol1986https://conductscience.org/library/papers/3086752PubMed
3035087Disturbed function of the pineal gland in familial amyloid polyneuropathy.J Neural Transm1987https://conductscience.org/library/papers/3035087PubMed
2900290The aortic alpha 1-adrenergic receptor in familial amyloidotic polyneuropathy.J Neural Transm1988https://conductscience.org/library/papers/2900290PubMed
2156957Acute autonomic and sensory neuropathy: a case report.J Neurol1990https://conductscience.org/library/papers/2156957PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/6287350

GET https://conductscience.org/api/papers/v1/6287350/authors